Debt (Details Narrative) - USD ($)			1 Months Ended		3 Months Ended		12 Months Ended
	Mar. 26, 2025	Sep. 30, 2024	Dec. 31, 2024	Sep. 30, 2024	Mar. 31, 2025	Mar. 31, 2024	Dec. 31, 2024	Feb. 03, 2025
Debt Instrument [Line Items]
Long term debt			$ 28,000,000.0		$ 377,000,000.0		$ 28,000,000.0
Long term debt availability			7,200,000		98,000,000.0		7,200,000
Interest Expense, Operating and Nonoperating					1,200,000
Unamortized deferred financing costs			1,731,000		14,117,000		1,731,000
Fair Value Adjustment of Warrants			800,000		800,000
Payments on senior convertible note					1,233,000
Stock issued during period value conversion of convertible securities					18,164,000
Fair value of subordinated					0
Payment on subordinated note related party					3,214,000
Subordinated note			4,609,000		1,458,000		4,609,000
Senior Convertible Note [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		8.00%		8.00%
Debt Instrument, Maturity Date		Sep. 30, 2025
Debt Conversion, Converted Instrument, Rate		105.00%
Debt principal balance							11,300,000
Fair value of convertible debt			12,600,000				12,600,000
Stock issued during period value conversion of convertible securities					$ 11,300,000
Stock issued during period value conversion of convertible securities, shares					2,100,000
Loss on adjustment to fair value debt and warrants					$ 5,500,000
Subordinated Promissory Note [Member]
Debt Instrument [Line Items]
Debt Instrument, Maturity Date				Dec. 31, 2025
Fair value of subordinated		$ 5,000,000.0		$ 5,000,000.0
Interest rate		10.00%		10.00%
Subordinated Note [Member]
Debt Instrument [Line Items]
Fair value of subordinated			3,200,000		$ 1,500,000		$ 3,200,000
Interest rate	15.00%
Payment on subordinated note related party			$ 1,800,000
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right		1,141,552	570,778	1,141,552	570,778		570,778
Fair value of subordinated			$ 4,600,000				$ 4,600,000
Paid subordinated note amount	$ 3,200,000
Subordinated note	$ 1,500,000
Credit Facility [Member]
Debt Instrument [Line Items]
Unamortized deferred financing costs			1,700,000		$ 14,100,000		1,700,000
Minimum [Member]
Debt Instrument [Line Items]
Commitment fee percentage					0.375%
Maximum [Member]
Debt Instrument [Line Items]
Commitment fee percentage					0.50%
Secured Overnight Financing Rate (SOFR) [Member]
Debt Instrument [Line Items]
Annum interest rate adjustment percentage					0.10%
Secured Overnight Financing Rate (SOFR) [Member] | Minimum [Member]
Debt Instrument [Line Items]
Debt instrument interest rate percentage					2.75%
Secured Overnight Financing Rate (SOFR) [Member] | Maximum [Member]
Debt Instrument [Line Items]
Debt instrument interest rate percentage					3.75%
Alternate Base Rate Loans [Member] | Minimum [Member]
Debt Instrument [Line Items]
Debt instrument interest rate percentage					1.75%
Alternate Base Rate Loans [Member] | Maximum [Member]
Debt Instrument [Line Items]
Debt instrument interest rate percentage					2.75%
Amended and Restated the Credit Facility Agreement [Member]
Debt Instrument [Line Items]
Line of credit facility, expiration date	Mar. 26, 2029
Line of credit	$ 1,000,000,000.0				$ 47,500,000
Elected commitment					475,000,000.0
Issuance of letter of credit					$ 475,000,000.0
Credit Facility Agreement [Member]
Debt Instrument [Line Items]
Debt instrument interest rate ratio					Net Leverage Ratio (as defined in the Amended & Restated Credit Agreement) of no greater than 3.00 to 1.00 and a Current Ratio (as defined in the Amended & Restated Credit Agreement) of at least 1.00 to 1.00. The Amended & Restated Credit Agreement also includes conditional equity cure rights that will enable the Company to cure certain breaches of these financial maintenance covenants. Further, beginning April 1, 2025, the Amended & Restated Credit Agreement requires the Company and its restricted subsidiaries to always hedge not less than 80% of projected production from their proved developed producing reserves and certain wells through March 31, 2028.
Credit Facility Agreement [Member] | Senior Convertible Note [Member]
Debt Instrument [Line Items]
Payments on senior convertible note			3,700,000
Standby Equity Purchase Agreement [Member]
Debt Instrument [Line Items]
Structuring fee		$ 25,000,000
Stock Issued During Period, Shares, Issued for Services		100,000
Common Stock, Terms of Conversion		Any purchases under an Advance will be subject to certain limitations, including that Yorkville cannot acquire (i) any shares that would result in Yorkville, including its affiliates, beneficially owning more than 4.99% of the Company’s outstanding Common Stock at the time of an Advance or (ii) more than 19.99% of the Company’s issued and outstanding Common Stock as of the SEPA Effective Date (the “Exchange Cap”), subject to limited exceptions. Pursuant to the SEPA, the Company may issue up to a total of
Standby Equity Purchase Agreement [Member] | Maximum [Member]
Debt Instrument [Line Items]
Sale of Stock, Consideration Received on Transaction		$ 40,000,000.0
SEPA Registration Rights Agreement [Member]
Debt Instrument [Line Items]
Borrowing from convertible debt		$ 15,000,000.0		$ 15,000,000.0
Stock Issued During Period, Shares, New Issues		4,198,343
Debt Instrument, Fair Value Disclosure			$ 800,000		$ 0		$ 800,000
Bayswater Acquisition [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity								$ 60,000,000.0